{"id":"W2953433507","doi":"10.1016/j.jval.2019.04.117","title":"PBI35 QUALITY-OF-LIFE OUTCOMES COMPARING THE PROPOSED BIOSIMILAR MSB11022 TO REFERENCE ADALIMUMAB IN PATIENTS WITH MODERATE-TO-SEVERE CHRONIC PLAQUE-TYPE PSORIASIS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Research on Leishmaniasis Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Adalimumab; Medicine; Dermatology Life Quality Index; Psoriasis Area and Severity Index; Biosimilar; Psoriatic arthritis; Visual analogue scale; Psoriasis; Bioequivalence; Internal medicine; Quality of life (healthcare); Clinical endpoint; Randomized controlled trial; Physical therapy; Rheumatoid arthritis; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001316009,0.0003143163,0.001005451,0.0002130717,0.0001552524,0.0007255864,0.0002144591,0.0004634581,0.002344507],"category_scores_gemma":[0.002264775,0.0001227662,0.001901153,0.0002708489,0.0002954451,0.0003986635,0.0003618418,0.001106166,0.0001781121],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000711085,"about_ca_system_score_gemma":0.00047745,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009723317,"about_ca_topic_score_gemma":0.001024958,"domain_scores_codex":[0.9992629,0.0003756404,0.00007714828,0.000107239,0.00008835921,0.0000886954],"domain_scores_gemma":[0.9989737,0.0003976646,0.0003145472,0.00006102341,0.0001039221,0.0001491412],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8158892,0.003744202,0.05193741,0.002135857,0.009243498,0.0001259182,0.0002950335,0.002224305,0.006083569,0.0005442215,0.001808663,0.105968],"study_design_scores_gemma":[0.1306493,0.4022796,0.4255178,0.0007393992,0.01888667,0.0006938346,0.0007480197,0.007365017,0.004978349,0.001380311,0.00661322,0.0001484699],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945362,0.003941716,0.0001446467,0.0001327047,0.00005325906,0.00006697603,0.0002941095,0.000005309711,0.0008251471],"genre_scores_gemma":[0.9990438,0.000320318,0.0001037035,0.00007850951,0.00003398653,0.0000311359,0.0002532277,9.357948e-7,0.0001344242],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002344507,"threshold_uncertainty_score":0.007843196,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1088192323538888,"score_gpt":0.3679393811453456,"score_spread":0.2591201487914568,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}